awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q53828883-1E85BD0E-0401-4FE3-AE8D-DAA4A1E1D3BD
Q53828883-1E85BD0E-0401-4FE3-AE8D-DAA4A1E1D3BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53828883-1E85BD0E-0401-4FE3-AE8D-DAA4A1E1D3BD
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.
P2860
Q53828883-1E85BD0E-0401-4FE3-AE8D-DAA4A1E1D3BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53828883-1E85BD0E-0401-4FE3-AE8D-DAA4A1E1D3BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eaf9323e5821815ee9043745a4d488cddc9b111c
P2860
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.